It has been established that PTX can destroy stromal density and inhibit the cytidine deaminase (CDA) that induces the GEM metabolic inactivation via upregulating oxidative stress (HO-1), thereby enhancing the therapeutic delivery of GEM into tumor sites21,35,53,54. The gene discussed is CDA; the disease is neoplasm.